Article
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.
Transplantation - 27 Nov 2009
Selzner Nazia, Renner Eberhard L, Selzner Markus, Adeyi Oyedele, Kashfi Arash, Therapondos George, Girgrah Nigel, Herath Chaturika, Levy Gary A, Lilly Leslie
Abstract excerpt
BACKGROUND: Efficacy and long-term outcome of antiviral therapy for recurrent hepatitis C after liver transplantation is poorly defined. AIM: This study aimed at assessing the efficacy of antiviral therapy regarding sustained hepatitis C virus (HCV) clearance, liver histology, and patient survival. METHODS: We retrospectively reviewed all 446 patients who received a liver allograft at our institution for...
Topics
- Adrenal Cortex Hormones
- Adult
- Aged
- Antiviral Agents
- Drug Tolerance
- Female
- Follow-Up Studies
- Genotype
- Hepatitis C
- Humans
- Immunosuppressive Agents